Natco Pharma Receives EIR from US FDA for Kothur facility

Natco Pharma has received establishment inspection report (EIR) from the US health regulator for its Kothur facility in Telangana after successful completion of inspection.


Natco Pharma has got EIR from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility at Kothur village in Mahabubnagar district during January 16-24, 2017, the company said in a BSE filing today.

“The Kothur facility predominantly caters to regulated international markets, including USA,” it added.

EIR is given to an establishment after completion of inspection by the USFDA.

The Natco Pharma stock was trading 1.05 per cent higher at Rs. 1,009 on the BSE.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top